Suzhou Alphamab Co., Ltd.
Suzhou Alphamab Co., Ltd.
Explore linked clinical trials.8 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety of KN057 Prophylaxis in Patients With Haemophilia A or B | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, blood coagulation disease, coagulation protein disease, hematologic disorder, hemophilia A, hemorrhagic disease, hereditary disease, inherited blood coagulation disorder | Recruiting | Phase 3 | 2026-04-22 | NCT07545395 | |
| To Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of KN060 in ESRD Dialysis Patients | End-Stage Renal Disease Requiring Haemodialysis | Recruiting | Phase 1 / Phase 2 | 2025-10-01 | NCT07201467 | |
| To Evaluate the Efficacy and Safety of KN060 in Essential Hypertension | cardiovascular disorder, essential hypertension, hypertensive disorder, vascular disorder | Recruiting | Phase 1 | 2025-09-25 | NCT07191899 | |
| Efficacy and Safety of KN057 Prophylaxis in Patients With Haemophilia A or B Without Inhibitors | Hemophilia A Without Inhibitor; Hemophilia B Without Inhibitor | Active, not recruiting | Phase 3 | 2025-09-17 | NCT06569108 | |
| A Study to Evaluate Features of KN069 in Participants With Obesity or Overweight | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Recruiting | Phase 1 | 2025-09-17 | NCT06547775 | |
| Efficacy and Safety of KN057 Prophylaxis in Patients With Haemophilia A or B With Inhibitors | Hemophilia A With Inhibitor; Hemophilia B With Inhibitor | Active, not recruiting | Phase 3 | 2025-09-17 | NCT06312475 | |
| Factor XI inhibiTion for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty | Knee Arthroplasty, Total | Active, not recruiting | Phase 2 | 2025-09-17 | NCT06180889 | |
| KN057 Multiple Dose Study in Patients with Hemophilia a or Hemophilia B with or Without Inhibitors | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, blood coagulation disease, coagulation protein disease, hematologic disorder, hemophilia A, hemorrhagic disease, hereditary disease, inherited blood coagulation disorder | Not yet recruiting | Phase 2 | 2024-12-24 | NCT06747416 |